Skip to main navigation Skip to search Skip to main content

Therapeutic effect of repetitive transcranial magnetic stimulation on non-lesional focal refractory epilepsy

  • Sungkyunkwan University
  • The Catholic University of Korea, St. Vincent's Hospital

Research output: Contribution to journalArticlepeer-review

16 Scopus citations

Abstract

The effects of repetitive transcranial magnetic stimulation (rTMS) on epilepsy remain unclear. This study was performed to investigate the effects of low-frequency rTMS on non-lesional focal epilepsy. This was a prospective open-label longitudinal study with four patients with multi-drug-resistant non-lesional focal epilepsy and no control group. The patients received daily doses of 900 pulses of 0.5-Hz stimulation for 10 days over the epileptic foci in neocortical areas determined by electrical source analysis. The outcomes were measured in terms of seizure reduction. The incidences of seizures were measured at baseline (4 weeks), intervention (2 weeks), and follow up (8 weeks). Seizure reduction was observed in three of four subjects. The effects of rTMS persisted over a follow-up period of 8 weeks. One of the four patients did not respond to rTMS and showed no seizure reduction. The low frequency rTMS would be an effective treatment for non-lesional focal refractory epilepsy, may be an adjunctive treatment with conventional medical treatment for refractory epilepsy. These results are therefore useful for planning treatment strategies for patients with refractory epilepsy, as well as for treatment of epilepsy.

Original languageEnglish
Pages (from-to)130-133
Number of pages4
JournalJournal of Clinical Neuroscience
Volume63
DOIs
StatePublished - May 2019

Bibliographical note

Publisher Copyright:
© 2019 Elsevier Ltd

Keywords

  • Epilepsy
  • Focal epilepsy
  • Refractory epilepsy
  • Seizure
  • Transcranial magnetic stimulation
  • rTMS

Fingerprint

Dive into the research topics of 'Therapeutic effect of repetitive transcranial magnetic stimulation on non-lesional focal refractory epilepsy'. Together they form a unique fingerprint.

Cite this